What is NDC 63187-583?

63187-583 is the product NDC for Zonisamide, Zonisamide 100 mg/1 capsule, listed with the FDA by Proficient Rx LP. It has 3 package NDCs, shown above in 10- and 11-digit form.

Proficient Rx LP, NDC labeler code 63187. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Zonisamide?

47 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Zonisamide NDC 63187-583 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)63187-583Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63187-0583Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
63187-583-30	63187058330	30 CAPSULE in 1 BOTTLE (63187-583-30)Marketed from Dec 1, 2018
63187-583-60	63187058360	60 CAPSULE in 1 BOTTLE (63187-583-60)Marketed from Dec 1, 2018
63187-583-90	63187058390	90 CAPSULE in 1 BOTTLE (63187-583-90)Marketed from Dec 1, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Zonisamide
Generic name (nonproprietary): zonisamide
Active ingredients: Zonisamide — 100 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Proficient Rx LPNDC labeler code 63187
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077651
Marketing start: Jan 30, 2006
Listing expires: Dec 31, 2026
Other FDA classes: Carbonic Anhydrase Inhibitors (Mechanism)Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)P-Glycoprotein Inhibitors (Mechanism)Sulfonamides (Chemical structure)
Identifiers: Product ID 63187-583_81a1a2d9-e7d9-4738-9d4d-fd70c9e4618fSPL ID 81a1a2d9-e7d9-4738-9d4d-fd70c9e4618fSPL set ID 85321a9a-08d9-49e4-8c79-86ecfc536613RxCUI 314285UNII 459384H98VUPC 0363187583309
Pharmacologic class: Anti-epileptic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463187058330 followed by a unit qualifier and the quantity

Package 63187-0583-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 1, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE Zonisamide capsules USP are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 63187-583

What is NDC 63187-583?: 63187-583 is the product NDC for Zonisamide, Zonisamide 100 mg/1 capsule, listed with the FDA by Proficient Rx LP. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Zonisamide.
What is the active ingredient?: Zonisamide.
Who is the labeler?: Proficient Rx LP, NDC labeler code 63187. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Zonisamide?: 47 other product NDCs are listed under this name. See all Zonisamide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Zonisamide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Zonisamide	Zonisamide 25 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4600	70518-4600-0070518-4600-02
Zonisamide	Zonisamide 50 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4349	70518-4349-00
Zonisamide	Zonisamide 25 mg/1	CapsuleOral	Direct_Rx	72189-624	72189-0624-72
Zonisamide	Zonisamide 100 mg/1	CapsuleOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0392	80425-0392-0180425-0392-02
Zonisamide	Zonisamide 100 mg/1	CapsuleOral	Advanced Rx of Tennessee, LLC	80425-0370	80425-0370-01
Zonisamide	Zonisamide 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-3903	70518-3903-00
Zonisamide	Zonisamide 25 mg/1	CapsuleOral	Direct_Rx	72189-374	72189-0374-72
Zonisamide	Zonisamide 25 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-2796	71335-2796-0171335-2796-0271335-2796-03+1 more
Zonisamide	Zonisamide 100 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-2797	71335-2797-0171335-2797-0271335-2797-03+2 more
Zonisamide	Zonisamide 25 mg/1	CapsuleOral	Viona Pharmaceuticals Inc	72578-040	72578-0040-0172578-0040-05

All 48 Zonisamide NDCs

Other NDCs under ANDA 077651

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077651
Product	Strength	Form · route	Labeler	Product NDC
Zonisamide	Zonisamide 25 mg/1	CapsuleOral	BluePoint Laboratories	68001-242
Zonisamide	Zonisamide 50 mg/1	CapsuleOral	BluePoint Laboratories	68001-243
Zonisamide	Zonisamide 100 mg/1	CapsuleOral	BluePoint Laboratories	68001-244
Zonisamide	Zonisamide 25 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4600
Zonisamide	Zonisamide 25 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-2798
Zonisamide	Zonisamide 100 mg/1	CapsuleOral	Glenmark Pharmaceuticals Inc., USA	68462-130
Zonisamide	Zonisamide 25 mg/1	CapsuleOral	Glenmark Pharmaceuticals Inc., USA	68462-128
Zonisamide	Zonisamide 50 mg/1	CapsuleOral	Glenmark Pharmaceuticals Inc., USA	68462-129